Vasculitis Trial, Recruiting (NCT07664228)

Vasculitis Trial, Recruiting NCT07664228 Sponsor: Bursa City Hospital Condition: Vasculitis

Printed from Voxsanity (voxsanity.com.au) — NCT07664228 — Data sourced from ClinicalTrials.gov. Verify directly with the trial site before attending. Not medical advice.

Back to Vasculitis

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

The child has been diagnosed with IgA vasculitis (also known as Henoch-Schönlein purpura) based on recognised medical classification guidelines.
The child is between 2 and 18 years old.
A blood sample can be taken from the child at the time of their diagnosis (the first visit).
The child is able to attend a follow-up appointment roughly 2 to 4 weeks after their diagnosis.
A parent or legal guardian is willing and able to sign a consent form on the child's behalf.

Who may not be able to join:

The parent or legal guardian does not agree to give written consent for the child to take part.
It is not possible to collect a blood sample from the child at the start of the study.
The child is unable to complete the follow-up visits or procedures required by the study.

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.

Last synced 26 July 2026

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Tuba Kurt, MD, Associate Professor, Health Sciences University Bursa City Hospital, Department of Pediatric Rheumatology

Phone: +90 5064767328

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Voxsanity

Clinical trials and treatments, explained plainly · voxsanity.com.au

Date:

To: My Doctor

Re: Clinical trial enquiry

I am writing to enquire about the following clinical trial which may be relevant to my care:

Trial: NCT07664228

Sponsor: Bursa City Hospital

Phase: Not Applicable

Status: Recruiting

Condition: Vasculitis

Trial contact: +90 5064767328

More information: https://clinicaltrials.gov/study/NCT07664228

Eligibility summary (AI generated)

Written by an AI model from the ClinicalTrials.gov eligibility criteria and checked on a sample basis. Please confirm against the original criteria.

Who might be able to join this trial:

The child has been diagnosed with IgA vasculitis (also known as Henoch-Schönlein purpura) based on recognised medical classification guidelines.
The child is between 2 and 18 years old.
A blood sample can be taken from the child at the time of their diagnosis (the first visit).
The child is able to attend a follow-up appointment roughly 2 to 4 weeks after their diagnosis.
A parent or legal guardian is willing and able to sign a consent form on the child's behalf.

Who may not be able to join:

The parent or legal guardian does not agree to give written consent for the child to take part.
It is not possible to collect a blood sample from the child at the start of the study.
The child is unable to complete the follow-up visits or procedures required by the study.

Important: Always verify eligibility with the trial site directly before applying.

Access in Australia: A treatment being studied in a clinical trial is generally not yet listed on the PBS. Where a medicine is not approved or not available through a trial, the TGA Special Access Scheme may allow a doctor to access unapproved therapeutic goods for individual patients. See voxsanity.com.au/sas-navigator/ for a plain English explainer.

This information was sourced from ClinicalTrials.gov via Voxsanity (data last synced 26 July 2026). It is not medical advice. Please verify the trial's current status directly with the trial site before acting.

Trial details

Status

Recruiting

Phase

Not Applicable

Sponsor

Bursa City Hospital

Registry

ClinicalTrials.gov

Start date

15 May 2026

Est. completion

15 February 2027

Where this trial is recruiting

Turkey (Türkiye)

Primary endpoints

Plasma I-FABP Levels

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 26 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov